Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -114,379 | -72,857 | -35,480 | -97,773 | -67,565 |
| Depreciation Amortization | -272 | -56 | 26 | 644 | 556 |
| Income taxes - deferred | N/A | N/A | N/A | -1,058 | N/A |
| Accounts receivable | N/A | N/A | N/A | 94 | 88 |
| Accounts payable and accrued liabilities | 4,280 | -795 | 3,865 | 2,419 | 653 |
| Other Working Capital | 12,528 | 3,621 | 4,135 | 2,864 | 136 |
| Other Operating Activity | 8,836 | 9,488 | 470 | 12,319 | 10,433 |
| Operating Cash Flow | $-89,008 | $-60,598 | $-26,984 | $-80,492 | $-55,699 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -333 | -317 | -295 | -723 | -207 |
| Purchase Of Investment | -241,115 | -183,657 | -91,870 | -520,927 | -274,675 |
| Sale Of Investment | 361,942 | 276,205 | 155,443 | 428,933 | 334,049 |
| Investing Cash Flow | $120,495 | $92,231 | $63,278 | $-92,718 | $59,167 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 499 | 344 | 338 | 162,357 | 231 |
| Financing Cash Flow | $499 | $344 | $338 | $162,357 | $231 |
| Beginning Cash Position | 37,790 | 37,790 | 37,790 | 48,642 | 48,642 |
| End Cash Position | 69,777 | 69,767 | 74,421 | 37,790 | 52,341 |
| Net Cash Flow | $31,987 | $31,977 | $36,631 | $-10,852 | $3,698 |
| Free Cash Flow | |||||
| Operating Cash Flow | -89,008 | -60,598 | -26,984 | -80,492 | -55,699 |
| Capital Expenditure | -333 | -317 | -295 | -723 | -207 |
| Free Cash Flow | -89,340 | -60,915 | -27,279 | -81,215 | -55,906 |